Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus


  1. 2019
  2. E-pub ahead of print

    Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis. / Sellebjerg, Finn; Royen, Lydia; Soelberg Sørensen, Per; Oturai, Annette Bang; Jensen, Poul Erik Hyldgaard.

    In: Multiple Sclerosis Journal, 2019.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. E-pub ahead of print

    Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis. / Petersen, Eva Rosa; Søndergaard, Helle Bach; Laursen, Julie Hejgaard; Olsson, Anna Gabriella; Börnsen, Lars; Soelberg Sørensen, Per; Sellebjerg, Finn; Bang Oturai, Annette.

    In: Multiple Sclerosis Journal, 2019.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2018
  5. Published

    Diagnosis of multiple sclerosis : 2017 revisions of the McDonald criteria. / Thompson, Alan J; Banwell, Brenda L; Barkhof, Frederik; Carroll, William M; Coetzee, Timothy; Comi, Giancarlo; Correale, Jorge; Fazekas, Franz; Filippi, Massimo; Freedman, Mark S; Fujihara, Kazuo; Galetta, Steven L; Hartung, Hans Peter; Kappos, Ludwig; Lublin, Fred D; Marrie, Ruth Ann; Miller, Aaron E; Miller, David H; Montalban, Xavier; Mowry, Ellen M; Sorensen, Per Soelberg; Tintoré, Mar; Traboulsee, Anthony L; Trojano, Maria; Uitdehaag, Bernard M J; Vukusic, Sandra; Waubant, Emmanuelle; Weinshenker, Brian G; Reingold, Stephen C; Cohen, Jeffrey A.

    In: Lancet Neurology, Vol. 17, No. 2, 2018, p. 162-173.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Disability in progressive MS is associated with T2 lesion changes. / Ammitzbøll, C; Dyrby, T B; Lyksborg, M; Schreiber, K; Ratzer, R; Romme Christensen, J; Iversen, P; Magyari, M; Garde, E; Sørensen, P S; Siebner, H R; Sellebjerg, F.

    In: Multiple Sclerosis and Related Disorders, Vol. 20, 2018, p. 73-77.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. / Montalban, Xavier; Gold, Ralf; Thompson, Alan J; Otero-Romero, Susana; Amato, Maria Pia; Chandraratna, Dhia; Clanet, Michel; Comi, Giancarlo; Derfuss, Tobias; Fazekas, Franz; Hartung, Hans Peter; Havrdova, Eva; Hemmer, Bernhard; Kappos, Ludwig; Liblau, Roland; Lubetzki, Catherine; Marcus, Elena; Miller, David H; Olsson, Tomas; Pilling, Steve; Selmaj, Krysztof; Siva, Axel; Sorensen, Per Soelberg; Sormani, Maria Pia; Thalheim, Christoph; Wiendl, Heinz; Zipp, Frauke.

    In: Multiple Sclerosis Journal, Vol. 24, No. 2, 2018, p. 96-120.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Early versus later treatment start in multiple sclerosis : a register-based cohort study. / the Danish Multiple Sclerosis Group.

    In: European Journal of Neurology, Vol. 25, No. 10, 2018, p. 1262-e110.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Environmental modifiable risk factors for multiple sclerosis : Report from the 2016 ECTRIMS focused workshop. / Amato, Maria Pia; Derfuss, Tobias; Hemmer, Bernard; Liblau, Roland; Montalban, Xavier; Sørensen, Per Soelberg; Miller, David H; 2016 ECTRIMS Focused Workshop Group.

    In: Multiple Sclerosis Journal, Vol. 24, No. 5, 2018, p. 590-603.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis : the CLARITY Extension study. / Comi, Giancarlo; Cook, Stuart; Rammohan, Kottil; Soelberg Sorensen, Per; Vermersch, Patrick; Adeniji, Abidemi K; Dangond, Fernando; Giovannoni, Gavin.

    In: Therapeutic Advances in Neurological Disorders, Vol. 11, 2018, p. 1-11.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis : Results from the randomized extension trial of the CLARITY study. / Giovannoni, Gavin; Soelberg Sorensen, Per; Cook, Stuart; Rammohan, Kottil; Rieckmann, Peter; Comi, Giancarlo; Dangond, Fernando; Adeniji, Abidemi K; Vermersch, Patrick.

    In: Multiple Sclerosis Journal, Vol. 24, No. 12, 2018, p. 1594-1604.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Smoking affects the interferon beta treatment response in multiple sclerosis. / Petersen, Eva R; Oturai, Annette B; Koch-Henriksen, Nils; Magyari, Melinda; Sørensen, Per S; Sellebjerg, Finn; Søndergaard, Helle B.

    In: Neurology, Vol. 90, No. 7, 2018, p. e593-e600.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...19 Next

ID: 11025